CCO Infectious Disease Podcast

Treatment Options for Severe COVID-19 in Patients Who Are Immunocompromised

Episode Summary

Listen in as expert faculty discuss treatment options for people with severe or critical COVID-19 and review data supporting the use of antiviral therapy, steroids, and other immunomodulators.

Episode Notes

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss treatment strategies for people who have severe COVID-19, including: 

• Antiviral therapy with remdesivir 
• Dexamethasone and other systemic corticosteroids 
• Immunomodulators, such as JAK inhibitors or IL-6 inhibitors 
• Overviews of clinical trial data demonstrating how and when to use these therapies

Presenters:

Stephen Cantrill, MD, FACEP​
Associate Director and Medical Director (Retired) ​ 
Department of Emergency Medicine​ 
Denver Health Medical Center​ 
Associate Professor ​ 
Department of Emergency Medicine​ 
University of Colorado Health Sciences Center​ 
Denver, Colorado 

Rajesh T. Gandhi, MD​
Massachusetts General Hospital​ 
Professor of Medicine​ 
Harvard Medical School​ 
Boston, Massachusetts 

Payal K. Patel, MD, MPH, FIDSA​
Systemwide Director of Antimicrobial Stewardship​ 
Associate Professor, Division of Infectious Diseases​ 
Intermountain Health​ 
Salt Lake City, Utah 

Link to full program: 
https://bit.ly/4gu2gcU

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.